carbamazepine
Generic: carbamazepine
Labeler: golden state medical supply, inc.Drug Facts
Product Profile
Brand Name
carbamazepine
Generic Name
carbamazepine
Labeler
golden state medical supply, inc.
Dosage Form
TABLET
Routes
Active Ingredients
carbamazepine 200 mg/1
Manufacturer
Identifiers & Regulatory
Product NDC
51407-215
Product ID
51407-215_4aa97817-1330-a973-e063-6394a90a5ccf
Product Type
HUMAN PRESCRIPTION DRUG
Marketing Category
ANDA
Application Number
ANDA074649
Listing Expiration
2027-12-31
Marketing Start
1996-10-03
Pharmacologic Class
Established (EPC)
Mechanism of Action
Physiologic Effect
Normalized Code Variants
Searchable formats for this product NDC code
Digits Only
51407215
Hyphenated Format
51407-215
Supplemental Identifiers
RxCUI
UNII
NUI
Resolved Product View
Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.
Resolved Identity
Brand Name
carbamazepine (source: ndc)
Generic Name
carbamazepine (source: ndc)
Application Number
ANDA074649 (source: ndc)
Routes
source: ndc
Resolved Composition
Strengths
- 200 mg/1
Packaging
- 100 TABLET in 1 BOTTLE (51407-215-01)
- 1000 TABLET in 1 BOTTLE (51407-215-10)
Packages (2)
Ingredients (1)
Linked Drug Pages (1)
Raw FDA Data
View complete raw FDA NDC JSON payload
{"route": ["ORAL"], "spl_id": "4aa97817-1330-a973-e063-6394a90a5ccf", "openfda": {"nui": ["N0000008486", "N0000175751", "N0000185506", "N0000191266", "N0000187064", "N0000185507", "N0000185607"], "unii": ["33CM23913M"], "rxcui": ["308979"], "spl_set_id": ["8a1ce79d-18ea-f30b-e053-2995a90ad1fb"], "pharm_class_pe": ["Decreased Central Nervous System Disorganized Electrical Activity [PE]"], "pharm_class_epc": ["Mood Stabilizer [EPC]"], "pharm_class_moa": ["Cytochrome P450 3A4 Inducers [MoA]", "Cytochrome P450 1A2 Inducers [MoA]", "Cytochrome P450 2B6 Inducers [MoA]", "Cytochrome P450 2C9 Inducers [MoA]", "Cytochrome P450 2C19 Inducers [MoA]"], "manufacturer_name": ["Golden State Medical Supply, Inc."]}, "finished": true, "packaging": [{"sample": false, "description": "100 TABLET in 1 BOTTLE (51407-215-01)", "package_ndc": "51407-215-01", "marketing_start_date": "20190509"}, {"sample": false, "description": "1000 TABLET in 1 BOTTLE (51407-215-10)", "package_ndc": "51407-215-10", "marketing_start_date": "20190509"}], "brand_name": "Carbamazepine", "product_id": "51407-215_4aa97817-1330-a973-e063-6394a90a5ccf", "dosage_form": "TABLET", "pharm_class": ["Cytochrome P450 1A2 Inducers [MoA]", "Cytochrome P450 2B6 Inducers [MoA]", "Cytochrome P450 2C19 Inducers [MoA]", "Cytochrome P450 2C9 Inducers [MoA]", "Cytochrome P450 3A4 Inducers [MoA]", "Decreased Central Nervous System Disorganized Electrical Activity [PE]", "Mood Stabilizer [EPC]"], "product_ndc": "51407-215", "generic_name": "Carbamazepine", "labeler_name": "Golden State Medical Supply, Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Carbamazepine", "active_ingredients": [{"name": "CARBAMAZEPINE", "strength": "200 mg/1"}], "application_number": "ANDA074649", "marketing_category": "ANDA", "marketing_start_date": "19961003", "listing_expiration_date": "20271231"}